{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:53:30Z","timestamp":1760576010803,"version":"build-2065373602"},"reference-count":7,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.clon.2014.02.005","type":"journal-article","created":{"date-parts":[[2014,3,3]],"date-time":"2014-03-03T21:45:57Z","timestamp":1393883157000},"page":"241-242","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Potential Clinical Exploitation of the Radiation-induced DNA Damage Response"],"prefix":"10.1016","volume":"26","author":[{"given":"R.P.","family":"Symonds","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.D.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.clon.2014.02.005_bib1","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.clon.2014.01.009","article-title":"Selective targeting of the G2\/M cell cycle checkpoint to improve the therapeutic index of radiotherapy","volume":"26","author":"Dillon","year":"2014","journal-title":"Clin Oncol"},{"issue":"5","key":"10.1016\/j.clon.2014.02.005_bib2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.clon.2014.02.004","article-title":"DNA double-strand break repair in a cellular context","volume":"26","author":"Shibata","year":"2014","journal-title":"Clin Oncol"},{"issue":"5","key":"10.1016\/j.clon.2014.02.005_bib3","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.clon.2014.02.007","article-title":"Poly(ADP-ribose)polymerase (PARP) inhibitors: from bench to bedside","volume":"26","author":"Plummer","year":"2014","journal-title":"Clin Oncol"},{"issue":"5","key":"10.1016\/j.clon.2014.02.005_bib4","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.clon.2014.02.006","article-title":"Emerging opportunities for the combination of molecularly targeted drugs with radiotherapy","volume":"26","author":"Searle","year":"2014","journal-title":"Clin Oncol"},{"issue":"5","key":"10.1016\/j.clon.2014.02.005_bib5","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.clon.2014.02.002","article-title":"The meaning, measurement and modification of hypoxia in the laboratory and the clinic","volume":"26","author":"Hammond","year":"2014","journal-title":"Clin Oncol"},{"issue":"5","key":"10.1016\/j.clon.2014.02.005_bib6","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.clon.2014.02.003","article-title":"Redox proteins and radiotherapy","volume":"26","author":"Zhang","year":"2014","journal-title":"Clin Oncol"},{"issue":"5","key":"10.1016\/j.clon.2014.02.005_bib7","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.clon.2014.02.001","article-title":"Finding the genetic determinants of adverse reactions to radiotherapy","volume":"26","author":"Rattay","year":"2014","journal-title":"Clin Oncol"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655514000727?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655514000727?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:40:35Z","timestamp":1760542835000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655514000727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":7,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0936655514000727"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2014.02.005","relation":{},"ISSN":["0936-6555"],"issn-type":[{"type":"print","value":"0936-6555"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential Clinical Exploitation of the Radiation-induced DNA Damage Response","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2014.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}